Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients
Conventional and Contrast-Assisted Frequency Functional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients
Conventional and Contrast-Assisted Frequency Functional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients
Sponsor study identifier
observational
10
1 country
1
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2018
Actual (reported)Study Completion
September 2018
Actual (reported)In this observational study the investigators will undertake imaging studies on men with prostate cancer. The primary hypothesis is that ultrasound spectroscopy could be used to determine the extent of disease inside and outside of the prostate gland in patients with prostate cancer. It is hoped that the changes in ultrasound backscatter parameters obtained before radical prostatectomy could be used to correlate with pathological findings from the prostate specimen after surgery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2018
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
September 1, 2010
Actual (reported)July 26, 2011
Actual (reported)September 2018
Actual (reported)September 2018
Actual (reported)ultrasound backscatter parameters such as aggregate mid-band fit, spectroscopic slope and intercept and the number of vessels with detectable blood flow and their sizes
These parameters will be obtained before radical prostatectomy to correlate with pathological findings from the prostate specimen after surgery.
Up to year 2019
sensitivity and specificity of ultrasound-based imaging of the prostate
Up to year 2019
The study will investigate a population of 30 men with prostate cancer undergoing radical prostatectomy surgery.
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
Prostate speciments are retained after radical prostatectomy surgery
Gregory Czarnota, PhD, M.D.
Sunnybrook Health Sciences Centre
10 participants (actual enrollment reported by the registry).
First Submitted
September 1, 2010
First Posted
July 26, 2011
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Observation or Radical Treatment in Patients With Prostate Cancer
Contact the study team to confirm eligibility.
Primary Completion
September 2018
Actual (reported)Study Completion
September 2018
Actual (reported)Last Updated
September 23, 2019
Record last verified: 2019-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: